Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Author: Felicia Rodriguez

FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease

FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell Disease

VIA: Today, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for

Read More »
3D Printed Synthetic Tissue and Bone is Here to Stay

3 ways 3D Printed Synthetic Body Parts are Transforming Medical Device Companies

VIA – Written by: Adam Fasnacht l Published in: 3D Printers If you work at a medical device company, you know that there are many situations that require using human body parts. More often than not, these come from cadavers and not 3D printed synthetic tissue.

Read More »
Roche Drug for Spinal Muscular Atrophy

Roche Drug for Spinal Muscular Atrophy Hits Target in Late-Stage Trial

VIA: ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function in a key study. Roche, which plans to seek approval for

Read More »
Career Change

4 Steps to Position Yourself for a Career Change

VIA: Published: Nov 05, 2019 By Porschia Parker   Have you ever made a career change? If so, how did it go? Most life sciences professionals are overwhelmed by the thought of making a career transition. Any type of change, whether it be to a

Read More »

Google Buys Fitbit For $2.1B, Stepping Back Into Wearables

VIA: – by Conor Hale | Nov 1, 2019   Google has moved to acquire Fitbit through a $2.1 billion deal that will subsume the company’s activity and fitness trackers along with its health-logging platform. The tech giant described the deal as an opportunity to “invest even

Read More »